These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33813379)

  • 21. Two cases of AML (M2) with a t(8;19)(q22;q13): a new cytogenetic variant.
    Xue Y; Niu C; Chen S; Wang Y; Guo Y; Xie X; Lu D; Li P
    Cancer Genet Cytogenet; 2000 Apr; 118(2):154-8. PubMed ID: 10748298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
    Ananthaneni A; Benzar T; Hafiz N; Akabane H
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
    Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
    Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.
    Murati A; Adélaïde J; Quilichini B; Rémy V; Sainty D; Stoppa AM; Bernard P; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
    Haematologica; 2007 Feb; 92(2):262-3. PubMed ID: 17296583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).
    Taki T; Shibuya N; Taniwaki M; Hanada R; Morishita K; Bessho F; Yanagisawa M; Hayashi Y
    Blood; 1998 Aug; 92(4):1125-30. PubMed ID: 9694699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute myeloid leukemia with t(11;12)(p15;q13) translocation: two cases report and literature review].
    Gong BF; Li QH; Li W; Wang Y; Wei H; Wang JY; Zhao XL; Lin D; Li CW; Liu XP; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):830-3. PubMed ID: 24171954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
    Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute myeloid leukemia M2and t (8; 19) (q22; q13)].
    Li P; Guo Y; Xie X; Wang Y; Lu D; Xue Y
    Zhonghua Xue Ye Xue Za Zhi; 2000 Feb; 21(2):84-6. PubMed ID: 11876965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.
    Marneth AE; Prange KHM; Al Hinai ASA; Bergevoet SM; Tesi N; Janssen-Megens EM; Kim B; Sharifi N; Yaspo ML; Kuster J; Sanders MA; Stoetman ECG; Knijnenburg J; Arentsen-Peters TCJM; Zwaan CM; Stunnenberg HG; van den Heuvel-Eibrink MM; Haferlach T; Fornerod M; Jansen JH; Valk PJM; van der Reijden BA; Martens JHA
    Leukemia; 2018 Mar; 32(3):828-836. PubMed ID: 28871137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1).
    Yamamoto K; Nagata K; Tsurukubo Y; Inagaki K; Ono R; Taki T; Hayashi Y; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Aug; 137(1):64-7. PubMed ID: 12377416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
    Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
    Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.
    Yan F; Li J; Milosevic J; Petroni R; Liu S; Shi Z; Yuan S; Reynaga JM; Qi Y; Rico J; Yu S; Liu Y; Rokudai S; Palmisiano N; Meyer SE; Sung PJ; Wan L; Lan F; Garcia BA; Stanger BZ; Sykes DB; Blanco MA
    Cancer Discov; 2022 Mar; 12(3):792-811. PubMed ID: 34853079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Myeloid Leukemia in an Infant with t(8;19)(p11.2;q13) Translocation: Case Report and a Review of the Literature.
    Eason AC; Bunting ST; Peterson JF; Saxe D; Sabnis HS
    Case Rep Hematol; 2019; 2019():4198415. PubMed ID: 31583141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
    Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
    Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).
    Takahashi T; Maruyama Y; Satoh Y; Yoshimoto M; Tsujisaki M
    Cancer Genet Cytogenet; 2004 Dec; 155(2):152-3. PubMed ID: 15571802
    [No Abstract]   [Full Text] [Related]  

  • 39. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature.
    Stark B; Resnitzky P; Jeison M; Luria D; Blau O; Avigad S; Shaft D; Kodman Y; Gobuzov R; Ash S
    Leuk Res; 1995 Jun; 19(6):367-79. PubMed ID: 7596149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.